JP2013520440A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013520440A5 JP2013520440A5 JP2012554079A JP2012554079A JP2013520440A5 JP 2013520440 A5 JP2013520440 A5 JP 2013520440A5 JP 2012554079 A JP2012554079 A JP 2012554079A JP 2012554079 A JP2012554079 A JP 2012554079A JP 2013520440 A5 JP2013520440 A5 JP 2013520440A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- formula
- pharmaceutically acceptable
- acceptable salt
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims 51
- 150000003839 salts Chemical class 0.000 claims 17
- 229910052799 carbon Inorganic materials 0.000 claims 7
- 238000000034 method Methods 0.000 claims 6
- -1 4-t-butoxyphenyl Chemical group 0.000 claims 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 4
- 125000000217 alkyl group Chemical group 0.000 claims 4
- 201000010099 disease Diseases 0.000 claims 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 3
- 201000004624 Dermatitis Diseases 0.000 claims 3
- 208000010668 atopic eczema Diseases 0.000 claims 3
- 239000003814 drug Substances 0.000 claims 3
- 229940079593 drug Drugs 0.000 claims 3
- 230000001404 mediated effect Effects 0.000 claims 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 3
- 125000004203 4-hydroxyphenyl group Chemical group [H]OC1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 2
- 206010012438 Dermatitis atopic Diseases 0.000 claims 2
- 201000004681 Psoriasis Diseases 0.000 claims 2
- 125000003118 aryl group Chemical group 0.000 claims 2
- 201000008937 atopic dermatitis Diseases 0.000 claims 2
- 125000001072 heteroaryl group Chemical group 0.000 claims 2
- 230000028993 immune response Effects 0.000 claims 2
- 229910052757 nitrogen Inorganic materials 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 208000023275 Autoimmune disease Diseases 0.000 claims 1
- 208000011231 Crohn disease Diseases 0.000 claims 1
- 206010020751 Hypersensitivity Diseases 0.000 claims 1
- 208000022559 Inflammatory bowel disease Diseases 0.000 claims 1
- 208000006877 Insect Bites and Stings Diseases 0.000 claims 1
- 206010033733 Papule Diseases 0.000 claims 1
- 206010039793 Seborrhoeic dermatitis Diseases 0.000 claims 1
- 206010040880 Skin irritation Diseases 0.000 claims 1
- 206010040914 Skin reaction Diseases 0.000 claims 1
- 206010052779 Transplant rejections Diseases 0.000 claims 1
- 208000024780 Urticaria Diseases 0.000 claims 1
- 208000030961 allergic reaction Diseases 0.000 claims 1
- 125000003277 amino group Chemical group 0.000 claims 1
- 230000001363 autoimmune Effects 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 208000024908 graft versus host disease Diseases 0.000 claims 1
- 208000015181 infectious disease Diseases 0.000 claims 1
- 230000002458 infectious effect Effects 0.000 claims 1
- 230000004054 inflammatory process Effects 0.000 claims 1
- 208000002551 irritable bowel syndrome Diseases 0.000 claims 1
- 201000011486 lichen planus Diseases 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 201000006417 multiple sclerosis Diseases 0.000 claims 1
- 230000004770 neurodegeneration Effects 0.000 claims 1
- 208000015122 neurodegenerative disease Diseases 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 206010039073 rheumatoid arthritis Diseases 0.000 claims 1
- 208000008742 seborrheic dermatitis Diseases 0.000 claims 1
- 230000036556 skin irritation Effects 0.000 claims 1
- 231100000475 skin irritation Toxicity 0.000 claims 1
- 230000035483 skin reaction Effects 0.000 claims 1
- 231100000430 skin reaction Toxicity 0.000 claims 1
- 210000004243 sweat Anatomy 0.000 claims 1
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 claims 1
- 230000002588 toxic effect Effects 0.000 claims 1
- 231100000563 toxic property Toxicity 0.000 claims 1
- 230000002110 toxicologic effect Effects 0.000 claims 1
- 231100000723 toxicological property Toxicity 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL390493A PL219569B1 (pl) | 2010-02-19 | 2010-02-19 | Cykliczne tetrapeptydy i ich zastosowanie |
| PLP.390493 | 2010-02-19 | ||
| PCT/US2011/025571 WO2011103524A2 (en) | 2010-02-19 | 2011-02-19 | Cyclic tetrapeptides and therapeutic applications thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013520440A JP2013520440A (ja) | 2013-06-06 |
| JP2013520440A5 true JP2013520440A5 (enExample) | 2014-04-10 |
| JP5901543B2 JP5901543B2 (ja) | 2016-04-13 |
Family
ID=44483608
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012554079A Expired - Fee Related JP5901543B2 (ja) | 2010-02-19 | 2011-02-19 | 環式テトラペプチド及びその治療応用 |
Country Status (13)
| Country | Link |
|---|---|
| US (3) | US20130224232A1 (enExample) |
| EP (1) | EP2536732B1 (enExample) |
| JP (1) | JP5901543B2 (enExample) |
| KR (1) | KR101704665B1 (enExample) |
| CN (1) | CN102858779B (enExample) |
| AU (1) | AU2011217882B2 (enExample) |
| BR (1) | BR112012020833A2 (enExample) |
| CA (1) | CA2827694C (enExample) |
| ES (1) | ES2611663T3 (enExample) |
| IL (2) | IL221535A (enExample) |
| PL (1) | PL219569B1 (enExample) |
| RU (1) | RU2568436C2 (enExample) |
| WO (1) | WO2011103524A2 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL219569B1 (pl) | 2010-02-19 | 2015-05-29 | Peptaderm Spółka Z Ograniczoną Odpowiedzialnością | Cykliczne tetrapeptydy i ich zastosowanie |
| US10421778B2 (en) | 2015-05-05 | 2019-09-24 | Washington University | Isoform-selective lysine deacetylase inhibitors |
| US10154997B2 (en) | 2015-08-04 | 2018-12-18 | Washington University | Treatment of parasitic diseases using KDAC inhibitor compounds |
| WO2018232285A1 (en) * | 2017-06-16 | 2018-12-20 | University Of Florida Research Foundation, Incorporated | Macrocyclic peptides and derivatives thereof with opioid activity |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3862925A (en) * | 1973-07-05 | 1975-01-28 | American Home Prod | Preparation of somatotropin release inhibiting factor and intermediates therefor |
| US3842067A (en) | 1973-07-27 | 1974-10-15 | American Home Prod | Synthesis of(des-asn5)-srif and intermediates |
| JPS5726506B2 (enExample) * | 1974-03-08 | 1982-06-04 | ||
| IT1077010B (it) * | 1976-09-01 | 1985-04-27 | Snam Progetti | Processo per la preparazione di copolimeri dell isobutilene contenenti insaturazioni ed atomi di alogeno reattivi |
| US4105603A (en) | 1977-03-28 | 1978-08-08 | The Salk Institute For Biological Studies | Peptides which effect release of hormones |
| JPH0334991A (ja) * | 1989-06-30 | 1991-02-14 | Shionogi & Co Ltd | 環状テトラペプチドおよびその製造法 |
| US5216124A (en) | 1989-12-15 | 1993-06-01 | G. D. Searle & Co. | Substituted cyclic tetrapeptides |
| US5541287A (en) | 1992-06-09 | 1996-07-30 | Neorx Corporation | Pretargeting methods and compounds |
| US6777217B1 (en) * | 1996-03-26 | 2004-08-17 | President And Fellows Of Harvard College | Histone deacetylases, and uses related thereto |
| US6013763A (en) | 1996-06-04 | 2000-01-11 | Genentech, Inc. | Peptide variants of protein A |
| NZ507083A (en) * | 1998-03-23 | 2003-10-31 | Trimeris Inc | Methods and compositions for peptide synthesis, in particular T-20 (DP-178) and T-20-like peptides |
| US6281331B1 (en) | 1998-03-23 | 2001-08-28 | Trimeris, Inc. | Methods and compositions for peptide synthesis |
| DE19816922A1 (de) | 1998-04-16 | 1999-10-21 | Wolfgang Beck | Einfache Synthese von cyclischen Tetrapeptiden aus nichtaktivierten Peptidestern an Metallzentren |
| AUPP505798A0 (en) * | 1998-08-04 | 1998-08-27 | Fujisawa Pharmaceutical Co., Ltd. | Novel compound fr225497 substance |
| IL142531A0 (en) | 1998-10-13 | 2002-03-10 | Fujisawa Pharmaceutical Co | Cyclic peptide compound, processes for the preparation thereof and pharmaceutical compositions containing the same |
| GB9903087D0 (en) * | 1999-02-12 | 1999-03-31 | Glaxo Group Ltd | Process |
| ATE376556T1 (de) * | 2003-12-31 | 2007-11-15 | Hoffmann La Roche | Verfahren zur peptidsynthese unter verwendung einer reduzierten menge an entschützungsmittel |
| WO2006049597A1 (en) | 2004-10-27 | 2006-05-11 | Avanir Pharmaceuticals | Amino acid-derived compounds as modulators of the reverse cholesterol transport |
| US20080219962A1 (en) * | 2004-12-14 | 2008-09-11 | Biorunx Co., Ltd. | Method to Enhance the Bone Formation Activity of Bmp by Runx2 Acetylation |
| RU2450018C2 (ru) | 2006-08-23 | 2012-05-10 | Йеда Рисерч Энд Диверлопмент Ко. Лтд | Конъюгаты rgd-пептидов и фотосенсибилизаторов порфирина или (бактерио)хлорофилла и их применение |
| DK2257309T3 (da) | 2008-02-27 | 2020-01-20 | Yeda Res And Development Company Ltd | Rgd-(bakterie)chlorophyl-konjugater til anvendelse ved diagnose af tumorer, der omfatter nekrotiske domæner |
| WO2010006267A2 (en) * | 2008-07-11 | 2010-01-14 | University Of Kansas | Cyclic tetrapeptides |
| GB0918579D0 (en) | 2009-10-22 | 2009-12-09 | Imp Innovations Ltd | Gadd45beta targeting agents |
| PL219569B1 (pl) | 2010-02-19 | 2015-05-29 | Peptaderm Spółka Z Ograniczoną Odpowiedzialnością | Cykliczne tetrapeptydy i ich zastosowanie |
-
2010
- 2010-02-19 PL PL390493A patent/PL219569B1/pl unknown
-
2011
- 2011-02-19 US US13/579,933 patent/US20130224232A1/en not_active Abandoned
- 2011-02-19 RU RU2012139668/04A patent/RU2568436C2/ru not_active IP Right Cessation
- 2011-02-19 BR BR112012020833A patent/BR112012020833A2/pt not_active Application Discontinuation
- 2011-02-19 ES ES11745399.3T patent/ES2611663T3/es active Active
- 2011-02-19 KR KR1020127024471A patent/KR101704665B1/ko not_active Expired - Fee Related
- 2011-02-19 CN CN201180019907.7A patent/CN102858779B/zh not_active Expired - Fee Related
- 2011-02-19 WO PCT/US2011/025571 patent/WO2011103524A2/en not_active Ceased
- 2011-02-19 AU AU2011217882A patent/AU2011217882B2/en not_active Ceased
- 2011-02-19 EP EP11745399.3A patent/EP2536732B1/en not_active Not-in-force
- 2011-02-19 JP JP2012554079A patent/JP5901543B2/ja not_active Expired - Fee Related
- 2011-02-19 CA CA2827694A patent/CA2827694C/en not_active Expired - Fee Related
-
2012
- 2012-08-19 IL IL221535A patent/IL221535A/en not_active IP Right Cessation
- 2012-08-24 US US13/593,716 patent/US9382292B2/en not_active Expired - Fee Related
-
2013
- 2013-01-27 IL IL224410A patent/IL224410A/en not_active IP Right Cessation
-
2016
- 2016-07-04 US US15/201,565 patent/US10238713B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI694982B (zh) | 3-側氧基-3-(芳基胺基)丙酸酯,其製備程序,及其於製備吡咯酮的應用 | |
| JP2016040271A5 (enExample) | ||
| JP2012515142A5 (enExample) | ||
| JP2017533968A5 (enExample) | ||
| JP2014509322A5 (enExample) | ||
| JP2010523522A5 (enExample) | ||
| JP2017509586A5 (enExample) | ||
| JP2009541327A5 (enExample) | ||
| JP2011506566A5 (enExample) | ||
| JP2010539166A5 (enExample) | ||
| JP2009538910A5 (enExample) | ||
| JP2015535847A5 (enExample) | ||
| JP2013536188A5 (enExample) | ||
| JP2011523952A5 (enExample) | ||
| JP2009533323A5 (enExample) | ||
| RU2010113358A (ru) | Гуанидинсодержащие соединения, применимые в качестве антагонистов мускариновых рецепторов | |
| JP2013520440A5 (enExample) | ||
| AU2014364410A1 (en) | Process methods for phosphatidylinositol 3-kinase inhibitors | |
| JP2009539943A5 (enExample) | ||
| JP2015500842A5 (enExample) | ||
| JP2017508733A5 (enExample) | ||
| JP2013515037A5 (enExample) | ||
| JP2004525183A5 (enExample) | ||
| JP2016503401A5 (enExample) | ||
| JP2013518111A5 (enExample) |